ABCL-422 Subcutaneous Epcoritamab in Patients with Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study
Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2022）
关键词
ABCL,bispecific,large B-cell lymphoma,hematologic malignancy,non-Hodgkin lymphoma,Phase II
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要